title: Contrast-enhanced MR imaging in neuroimaging.
abstract: MR imaging without and with gadolinium-based contrast agents (GBCAs) is an important imaging tool for defining normal anatomy and characteristics of lesions. GBCAs have been used in contrast-enhanced MR imaging in defining and characterizing lesions of the central nervous system for more than 20 years. The combination of unenhanced and GBCA-enhanced MR imaging is the clinical gold standard for the noninvasive detection and delineation of most intracranial and spinal lesions. MR imaging has a high predictive value that rules out neoplasm and most inflammatory and demyelinating processes of the central nervous system.
authors.affiliation: Department of Radiology, The Catholic University of Korea, Seoul, Korea.
authors.forename: Bum-soo
authors.initials: BS
authors.lastname: Kim
authors.forename: Juan E
authors.initials: JE
authors.lastname: Gutierrez
mesh_terms: D001927:Brain Diseases / Q000175:diagnosis*; D003287:Contrast Media; D005682:Gadolinium; D006801:Humans; D007089:Image Enhancement / Q000379:methods*; D008279:Magnetic Resonance Imaging / Q000379:methods*; D009485:Neuroradiography / Q000379:methods*
chemical_list: D003287:Contrast Media; D005682:Gadolinium